Competition Law and Policy in the Japanese Pharmaceutical Sector
Springer Singapore
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
| Chapter title |
Will Authorised Biologics Deter Biosimilars?—Utilising JFTC’s Expertise in Drug Pricing
|
|---|---|
| Book title |
Competition Law and Policy in the Japanese Pharmaceutical Sector
|
| Published by |
Springer, Singapore, January 2022
|
| DOI | 10.1007/978-981-16-7814-1_11 |
| Book ISBNs |
978-9-81-167813-4, 978-9-81-167814-1
|
| Authors |
Takanori Abe, Abe, Takanori |